Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral Cancer

International Journal of Dentistry

Volumn 2013, Issue , 2013, Pages

  Prasad, Gareema ^a   McCullough, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893876856     PISSN: 16878728     EISSN: 16878736     Source Type: Journal    
DOI: 10.1155/2013/813756     Document Type: Article

References (72)

1. World Health Organisation (WHO), Global Data on Incidence of Oral Cancer 2005 WHO/NMH/CHP/HPR/ORH
2. Australian Institute of Health Welfare (AIHW), Australasian Association of Cancer Registries (AACR), Cancer in Australia: An Overview 2008 Canberra, Australia AIHW Cancer series no. 46. Cat. no. CAN 42
3. Neville B. W., Day T. A., Oral cancer and precancerous lesions. Cancer Journal for Clinicians 2002 52 4 195 215 2-s2.0-0036347157
4. Sciubba J. J., Oral cancer and its detection: history-taking and the diagnostic phase of management. Journal of the American Dental Association 2001 132 11 12S 18S 2-s2.0-0035524840 (Pubitemid 33741644)
5. Carew J. F., Singh B., Shah J. P., Clinical evaluation and differential diagnosis. Oral Cancer 2003 183 198
6. Gonsalves W. C., Chi A. C., Neville B. W., Common oral lesions: part II. Masses and neoplasia. The American Family Physician 2007 75 4 509 512 2-s2.0-33847749431 (Pubitemid 46397898)
7. McCullough M. J., Prasad G., Farah C. S., Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Australian Dental Journal 2010 55 61 65 2-s2.0-79958101833
8. Patton L. L., Epstein J. B., Kerr A. R., Adjunctive techniques for oral cancer examination and lesion diagnosis a systematic review of the literature. The Journal of the American Dental Association 2008 139 7 896 905 2-s2.0-47949120750
9. Cheng Y. S. L., Wright J., Advances in diagnostic adjuncts for oral squamous cell carcinoma. The Open Pathology Journal 2011 5 3 7
10. Zhang A., Sun H., Wang P., Wang X., Salivary proteomics in biomedical research. Clinica Chimica Acta 2013 415 261 265
11. Wong D. T. W., Salivaomics. The Journal of the American Dental Association 2012 143 19S 24S
12. Pereira L. H., Adebisi I. N., Perez A., Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection. Cancer Biomarkers 2011 10 5 241 249
13. Chang K.-P., Chang Y.-T., Liao C.-T., Yen T.-C., Chen I.-H., Chang Y.-L., Liu Y.-L., Chang Y.-S., Yu J.-S., Wu C.-C., Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clinica Chimica Acta 2011 412 11-12 980 987 2-s2.0-79954995142 10.1016/j.cca.2011.02.002
14. Elashoff D., Zhou H., Reiss J., Wang J., Xiao H., Henson B., Hu S., Arellano M., Sinha U., Le A., Messadi D., Wang M., Nabili V., Lingen M., Morris D., Randolph T., Feng Z., Akin D., Kastratovic D. A., Chia D., Abemayor E., Wong D. T. W., Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiology Biomarkers and Prevention 2012 21 4 664 672 2-s2.0-84859382029 10.1158/1055-9965.EPI-11-1093
15. Janeway C. A. Jr., Travers P., Walport M., Shlomchik M. J., Immunobiology: The Immune System in Health and Disease 1996 Churchill Livingstone
16. Dinarello C. A., Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. Journal of Biological Regulators and Homeostatic Agents 1997 11 3 91 103 2-s2.0-0031471921 (Pubitemid 28045963)
17. Piva M. R., de Souza L. B., Martins-Filho P. R., Role of inflammation in oral carcinogenesis (part II): CD8, FOXP3, TNF- α TGF- β and NF- B expression. Oncology Letters 2013 5 6 1909 1914
18. Costa N. L., Valadares M. C., Souza P. P., Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma. Oncology Letters 2013 49 3 216 223
19. Koontongkaew S., The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. Journal of Cancer 2013 4 1 66 83
20. Ling E., Robinson D. S., Transforming growth factor- β 1: its anti-inflammatory and pro-fibrotic effects. Clinical and Experimental Allergy 2002 32 2 175 178 2-s2.0-0036231985 10.1046/j.1365-2222.2002.01287.x (Pubitemid 34429592)
21. Scarano E., Fiorita A., Picciotti P. M., Passali G. C., Calò L., Cabras T., Inzitari R., Fanali C., Mesana I., Castagnola M., Paludetti G., Proteomics of saliva: personal experience. Acta Otorhinolaryngologica Italica 2010 30 3 125 130 2-s2.0-77955164814
22. Xiao H., Wong D. T., Proteomics and its applications for biomarker discovery in human saliva. Bioinformation 2011 5 7 294 296
23. Bandhakavi S., Stone M. D., Onsongo G., van Riper S. K., Griffin T. J., A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. Journal of Proteome Research 2009 8 12 5590 5600 2-s2.0-71549145619 10.1021/pr900675w
24. Schapher M., Wendler O., Gröschl M., Salivary cytokines in cell proliferation and cancer. Clinica Chimica Acta 2011 412 19-20 1740 1748 2-s2.0-79960632294 10.1016/j.cca.2011.06.026
25. Culig Z., Interleukin-6 as a therapy target in oral squamous carcinoma. Expert Opinion on Therapeutic Targets 2013 17 1 53 59
26. St John M. A., Li Y., Zhou X., Denny P., Ho C.-M., Montemagno C., Shi W., Qi F., Wu B., Sinha U., Jordan R., Wolinsky L., Park N.-H., Liu H., Abemayor E., Wong D. T. W., Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Archives of Otolaryngology 2004 130 8 929 935 2-s2.0-3843142873 10.1001/archotol.130.8.929 (Pubitemid 39045599)
27. Chen Z., Malhotra P. S., Thomas G. R., Ondrey F. G., Duffey D. C., Smith C. W., Enamorado I., Yeh N. T., Kroog G. S., Rudy S., McCullagh L., Mousa S., Quezado M., Herscher L. L., Van Waes C., Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clinical Cancer Research 1999 5 6 1369 1379 2-s2.0-0033017066 (Pubitemid 29282941)
28. Mann E. A., Spiro J. D., Chen L. L., Kreutzer D. L., Cytokine expression by head and neck squamous cell carcinomas. The American Journal of Surgery 1992 164 6 567 573 2-s2.0-0027034108
29. Woods K. V., El-Naggar A., Clayman G. L., Grimm E. A., Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Research 1998 58 14 3132 3141 2-s2.0-0032527621 (Pubitemid 28335097)
30. Wang Y.-F., Chang S.-Y., Tai S.-K., Li W.-Y., Wang L.-S., Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head and Neck 2002 24 9 850 858 2-s2.0-0036720811 10.1002/hed.10145 (Pubitemid 34913256)
31. Nibali L., Fedele S., D'Aiuto F., Donos N., Interleukin-6 in oral diseases: a review. Oral Diseases 2012 18 3 236 243 2-s2.0-84857796273 10.1111/j.1601-0825.2011.01867.x
32. Hwang Y. S., Lee S. K., Park K.-K., Chung W.-Y., Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption. Oral Oncology 2012 48 1 40 48 2-s2.0-84855884172 10.1016/j.oraloncology.2011.08.022
33. Tamura S., Ouchi K. F., Mori K., Endo M., Matsumoto T., Eda H., itsuka H. T., Tokita H., Yamaguchi K., Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. Clinical Cancer Research 1995 1 11 1353 1358 2-s2.0-0028792545
34. Karczewska A., Nawrocki S., Breborowicz D., Filas V., Mackiewicz A., Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer 2000 88 9 2061 2071 (Pubitemid 30233208)
35. Hodge D. R., Peng B., Cherry J. C., Hurt E. M., Fox S. D., Kelley J. A., Munroe D. J., Farrar W. L., Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Research 2005 65 11 4673 4682 2-s2.0-19644389279 10.1158/0008-5472.CAN-04-3589 (Pubitemid 40740803)
36. Sato J., Goto J., Murata T., Kitamori S., Yamazaki Y., Satoh A., Kitagawa Y., Changes in saliva interleukin-6 levels in patients with oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2010 110 3 330 336 2-s2.0-78049371680 10.1016/j.tripleo.2010.03. 040
37. McNamara M. J., Alexander H. R., Norton J. A., Cytokines and their role in the pathophysiology of cancer cachexia. Journal of Parenteral and Enteral Nutrition 1992 16 6 50S 55S 2-s2.0-0026467017
38. Korostoff A., Reder L., Masood R., Sinha U. K., The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncology 2011 47 4 282 287 2-s2.0-79953065587 10.1016/j.oraloncology.2011.02.006
39. Giannopoulou C., Kamma J. J., Mombelli A., Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. Journal of Clinical Periodontology 2003 30 2 145 153 2-s2.0-0037977863 10.1034/j.1600-051X. 2003.300201.x (Pubitemid 38019410)
40. Wang P.-L., Ohura K., Fujii T., Oido-Mori M., Kowashi Y., Kikuchi M., Suetsugu Y., Tanaka J., DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochemical and Biophysical Research Communications 2003 305 4 970 973 2-s2.0-0037566745 10.1016/S0006-291X(03)00821-0 (Pubitemid 36597858)
41. Arellano-Garcia M. E., Hu S., Wang J., Henson B., Zhou H., Chia D., Wong D. T., Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Diseases 2008 14 8 705 712 2-s2.0-54049143865 10.1111/j.1601-0825.2008.01488.x
42. Sahebjamee M., Eslami M., Atarbashimoghadam F., Sarafnejad A., Salivary concentration of TNF α IL1 α IL6, and IL8 in oral squamous cell carcinoma. Medicina Oral Patologia Oral y Cirugia Bucal 2008 13 5 292 295 2-s2.0-45549084189 (Pubitemid 351860663)
43. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity. Immunity 2000 12 2 121 127 2-s2.0-0034144269 (Pubitemid 30398626)
44. Ruffini P. A., Morandi P., Cabioglu N., Altundag K., Cristofanilli M., Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer 2007 109 12 2392 2404 2-s2.0-34250186076 10.1002/cncr.22706 (Pubitemid 46906457)
45. Olson T. S., Ley K., Chemokines and chemokine receptors in leukocyte trafficking. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2002 283 1 R7 R28 2-s2.0-0036333434 (Pubitemid 34863907)
46. Vinader V., Afarinkia K., Mini focus: chemokines-review a beginner's guide to chemokines. Future Medicinal Chemistry 2012 4 7 845 852
47. Gouwy M., Struyf S., Proost P., van Damme J., Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine and Growth Factor Reviews 2005 16 6 561 580 2-s2.0-27144464845 10.1016/j.cytogfr.2005.03. 005 (Pubitemid 41505517)
48. Callewaere C., Banisadr G., Rostène W., Parsadaniantz S. M., Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. Journal of Molecular Endocrinology 2007 38 3-4 355 363 2-s2.0-34248339649 10.1677/JME-06-0035 (Pubitemid 46729097)
49. Hyduk S. J., Chan J. R., Duffy S. T., Chen M., Peterson M. D., Waddell T. K., Digby G. C., Szaszi K., Kapus A., Cybulsky M. I., Phospholipase C, calcium, and calmodulin are critical for α 4 β 1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants. Blood 2007 109 1 176 184 2-s2.0-33846027057 10.1182/blood-2006-01-029199 (Pubitemid 46053059)
50. Sallusto F., Baggiolini M., Chemokines and leukocyte traffic. Nature Immunology 2008 9 9 949 952 2-s2.0-50049123401 10.1038/ni.f.214
51. Guerreiro R., Santos-Costa Q., Azevedo-Pereira J. M., The chemokines and their receptors: characteristics and physiological functions. Acta Médica Portuguesa 2011 24 4 967 976
52. Kunkel E. J., Butcher E. C., Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002 16 1 1 4 2-s2.0-0036166387 10.1016/S1074-7613(01) 00261-8 (Pubitemid 34143211)
53. Deshmane S. L., Kremlev S., Amini S., Sawaya B. E., Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 2009 29 6 313 326 2-s2.0-66149172257 10.1089/jir.2008.0027
54. Izadpanah A., Dwinell M. B., Eckmann L., Varki N. M., Kagnoff M. F., Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. The American Journal of Physiology- Gastrointestinal and Liver Physiology 2001 280 4 G710 G719
55. Morales J., Homey B., Vicari A. P., Hudak S., Oldham E., Hedrick J., Orozco R., Copeland N. G., Jenkins N. A., McEvoy L. M., Zlotnik A., CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proceedings of the National Academy of Sciences of the United States of America 1999 96 25 14470 14475 2-s2.0-0033405619 (Pubitemid 30000674)
56. Schutyser E., Struyf S., Menten P., Lenaerts J.-P., Conings R., Put W., Wuyts A., Proost P., Van Damme J., Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 α from normal and transformed cells. Journal of Immunology 2000 165 8 4470 4477 2-s2.0-0034667898
57. Struyf S., Proost P., van Damme J., Regulation of the immune response by the interaction of chemokines and proteases. Advances in Immunology 2003 81 1 44 2-s2.0-0142254121 10.1016/S0065-2776(03)81001-5 (Pubitemid 38009040)
58. Michiels K., Schutyser E., Conings R., Lenaerts J.-P., Put W., Nuyts S., Delaere P., Jacobs R., Struyf S., Proost P., Van Damme J., Carcinoma cell-derived chemokines and their presence in oral fluid. European Journal of Oral Sciences 2009 117 4 362 368 2-s2.0-67651250530 10.1111/j.1600-0722.2009. 00644.x
59. Proudfoot A. E. I., Power C. A., Rommel C., Wells T. N. C., Strategies for chemokine antagonists as therapeutics. Seminars in Immunology 2003 15 1 57 65 2-s2.0-0037300399 10.1016/S1044-5323(02)00128-8 (Pubitemid 36092179)
60. Gouwy M., Struyf S., Noppen S., Schutyser E., Springael J.-Y., Parmentier M., Proost P., Van Damme J., Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Molecular Pharmacology 2008 74 2 485 495 2-s2.0-47949092541 10.1124/mol.108.045146
61. Oliveira-Neto H. H., de Souza P. P., da Silva M. R., Mendonça E. F., Silva T. A., Batista A. C., The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumor Biology 2013 34 1 65 70
62. Oue E., Lee J. W., Sakamoto K., CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. Biochemical and Biophysical Research Communications 2012 424 3 456 461
63. Yeudall W. A., Vaughan C. A., Miyazaki H., Ramamoorthy M., Choi M.-Y., Chapman C. G., Wang H., Black E., Bulysheva A. A., Deb S. P., Windle B., Deb S., Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration. Carcinogenesis 2012 33 2 442 451 2-s2.0-84856579972 10.1093/carcin/bgr270
64. Thode C., Jørgensen T. G., Dabelsteen E., Mackenzie I., Dabelsteen S., Significance of myofibroblasts in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2011 40 3 201 207 2-s2.0-79951859622 10.1111/j.1600-0714.2010.00999.x
65. Chuang J.-Y., Yang W.-H., Chen H.-T., Huang C.-Y., Tan T.-W., Lin Y.-T., Hsu C.-J., Fong Y.-C., Tang C.-H., CCL5/CCR5 axis promotes the motility of human oral cancer cells. Journal of Cellular Physiology 2009 220 2 418 426 2-s2.0-67649342558 10.1002/jcp.21783
66. Weng C. J., Chien M. H., Lin C. W., Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer. Oral Oncology 2010 46 10 767 772 10.1016/j.oraloncology.2010.07.011
67. Chakraborty K., Bose A., Goswami K. K., Mukherjee K. K., Goswami S., Ghosh D., Chakraborty T., Sarkar K., Pal S., Bhowmick A., Biswas J., Baral R., Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α -2b. Human Immunology 2012 73 1 38 47 2-s2.0-84355161983 10.1016/j.humimm.2011.10.015
68. Teng Y.-H., Liu T.-H., Tseng H.-C., Chung T.-T., Yeh C.-M., Li Y.-C., Ou Y.-H., Lin L.-Y., Tsai H.-T., Yang S.-F., Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head and Neck 2009 31 10 1282 1288 2-s2.0-70349317159 10.1002/hed.21094
69. Clatot F., Picquenot J.-M., Choussy O., Gouérant S., Moldovan C., Schultheis D., Cornic M., Franois A., Blot E., Laberge-Le-Couteulx S., Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma. Oral Oncology 2011 47 11 1062 1068 2-s2.0-80054807678 10.1016/j.oraloncology.2011.07.021
70. Xia J., Chen N., Hong Y., Chen X., Tao X., Cheng B., Huang Y., Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions. Mediators of Inflammation 2012 2012 5 2-s2.0-84858129789 10.1155/2012/516395 516395
71. Yagi H., Tan W., Dillenburg-Pilla P., Armando S., Amornphimoltham P., Simaan M., Weigert R., Molinolo A. A., Bouvier M., Gutkind J. S., Cancer biology: a synthetic biology approach reveals a CXCR4-G13-rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Science Signaling 2011 4 191, article ra60 2-s2.0-80053124540 10.1126/scisignal.2002221
72. Yuvaraj S., Griffin A. C., Sundaram K., Kirkwood K. L., Norris J. S., Reddy S. V., A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells. Molecular Cancer Research 2009 7 8 1399 1407 2-s2.0-69449094082 10.1158/1541-7786.MCR-08-0589